These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6215479)

  • 1. [Pharmaceutical studies on hydrates of AM-715. Physical characteristics and intestinal absorption].
    Yuasa R; Imai J; Morikawa H; Kusajima H; Uchida H; Irikura T
    Yakugaku Zasshi; 1982 May; 102(5):469-76. PubMed ID: 6215479
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of norfloxacin in renal failure.
    Fillastre JP; Hannedouche T; Leroy A; Humbert G
    J Antimicrob Chemother; 1984 Oct; 14(4):439. PubMed ID: 6238930
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.
    Shimada J; Yamaji T; Ueda Y; Uchida H; Kusajima H; Irikura T
    Antimicrob Agents Chemother; 1983 Jan; 23(1):1-7. PubMed ID: 6219615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and tissue penetration of norfloxacin.
    Adhami ZN; Wise R; Weston D; Crump B
    J Antimicrob Chemother; 1984 Jan; 13(1):87-92. PubMed ID: 6230344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin--a review of pharmacology and tissue penetration.
    Wise R
    J Antimicrob Chemother; 1984 May; 13 Suppl B():59-64. PubMed ID: 6234277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential usefulness of norfloxacin in the treatment of urinary tract infections.
    Norrby SR
    Eur J Clin Microbiol; 1983 Jun; 2(3):227-9. PubMed ID: 6224677
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic studies of norfloxacin in laboratory animals.
    Gilfillan EC; Pelak BA; Bland JA; Malatesta PF; Gadebusch HH
    Chemotherapy; 1984; 30(5):288-96. PubMed ID: 6237890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of quinoline carboxylic acid derivatives in the dog prostate.
    Jensen KM; Madsen PO
    Prostate; 1983; 4(4):407-14. PubMed ID: 6223287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physico-chemical properties and biological activities of erythromycin nalidixate.
    Goswami BB; Manna PK; Basu SK
    Arzneimittelforschung; 1995 Jul; 45(7):813-4. PubMed ID: 8573228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norfloxacin disposition after sequentially increasing oral doses.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    Antimicrob Agents Chemother; 1983 Feb; 23(2):284-8. PubMed ID: 6220672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pipemidic acid: absorption, distribution, and excretion.
    Shimizu M; Nakamura S; Takase Y; Kurobe N
    Antimicrob Agents Chemother; 1975 Apr; 7(4):441-6. PubMed ID: 1147580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatography of pefloxacin and its main active metabolites in biological fluids.
    Montay G; Blain Y; Roquet F; Le Hir A
    J Chromatogr; 1983 Feb; 272(2):359-65. PubMed ID: 6220023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal intraprostatic concentrations of norfloxacin.
    Bologna M; Vaggi L; Forchetti CM; Martini E
    Lancet; 1983 Jul; 2(8344):280. PubMed ID: 6135100
    [No Abstract]   [Full Text] [Related]  

  • 14. Norfloxacin-induced rheumatic disease.
    Bailey RR; Kirk JA; Peddie BA
    N Z Med J; 1983 Jul; 96(736):590. PubMed ID: 6223241
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results.
    Hughes PJ; Webb DB; Asscher AW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():55-7. PubMed ID: 6234276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic concentrations of norfloxacin using HPLC].
    Bologna M; Cavicchio GC; Forchetti CM; Rucci A; Di Nicola G; Vaggi L
    G Ital Chemioter; 1984; 31(1-2):59-63. PubMed ID: 6236124
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.
    Montay G; Tassel JP
    J Chromatogr; 1985 Apr; 339(1):214-8. PubMed ID: 3160717
    [No Abstract]   [Full Text] [Related]  

  • 18. Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
    Panichi G; Pantosti A; Testore GP
    J Antimicrob Chemother; 1983 Jun; 11(6):589-92. PubMed ID: 6224769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of appearance of resistant variants to norfloxacin and nalidixic acid.
    Duckworth GJ; Williams JD
    J Antimicrob Chemother; 1984 May; 13 Suppl B():33-8. PubMed ID: 6234273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pefloxacine: diffusion into bronchial mucus].
    Morel C; Vergnaud M; Langeard M; Benard Y
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):516-9. PubMed ID: 6589585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.